Open-label Evaluation of the Pharmacokinetic Profile, Safety, and Efficacy of Tapentadol Oral Solution for the Treatment of Post-surgical Pain in Children and Adolescents Aged From 2 Years to Less Than 18 Years

Trial Profile

Open-label Evaluation of the Pharmacokinetic Profile, Safety, and Efficacy of Tapentadol Oral Solution for the Treatment of Post-surgical Pain in Children and Adolescents Aged From 2 Years to Less Than 18 Years

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Aug 2015

At a glance

  • Drugs Tapentadol (Primary)
  • Indications Postoperative pain
  • Focus Pharmacokinetics
  • Sponsors Grunenthal
  • Most Recent Events

    • 04 Mar 2014 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 05 Oct 2013 Planned end date changed from 1 Nov 2013 to 1 Mar 2014 as reported by ClinicalTrials.gov.
    • 05 Oct 2013 Planned number of patients changed from 52 to 56 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top